Vaccination against SARS-CoV-2 in rheumatic diseases: Safety issues
The problem of coronavirus disease 2019 (Coronavirus diseases, COVID-19) two years later still remains relevant both socially and medically. As one of the methods of combating the current COVID-19 pandemic, most experts rely on the widespread use of vaccination. However, the use of vaccines against...
Saved in:
| Main Authors: | B. S. Belov, A. M. Lila, E. L. Nasonov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2022-03-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/3112 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity of Vaccines Against SARS-CoV-2 In Patients With Rheumatic Diseases
by: B. B. BELOV, et al.
Published: (2022-09-01) -
The use of the combined vector vaccine GamCOVID-Vac (Sputnik V) in patients with immuno-inflammatory rheumatic diseases: safety issues-news
by: A. N. Kulikov, et al.
Published: (2023-06-01) -
Vaccination for rheumatic diseases: Current issues (based on ACR guidelines)
by: B. S. Belov, et al.
Published: (2023-04-01) -
Pneumococcal vaccination in rheumatic diseases: 10 years of application experience at the V.A. Nasonova Research Institute of Rheumatology
by: B. S. Belov, et al.
Published: (2022-07-01) -
To the 100th anniversary of the birth of academician V.A. Nasonova. Infections and rheumatic diseases: from the past to the future
by: B. S. Belov, et al.
Published: (2023-03-01)